Arcadia Biosciences (RKDA) Reports Q4 Revenues Above Estimates
Arcadia Biosciences (NASDAQ: RKDA) reported Q4 revenue for the quarter came in at $1.43 million versus the consensus estimate of $800 thousand.
For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.
